Neko Health raises $700 million ahead of New York launch

Neko Health, the preventive health startup co-founded by Spotify’s Daniel Ek and Hjalmar Nilsonne, has raised $700 million in new funding as it gets ready to enter the U.S. market. For retail investors watching private tech, the round shows how much capital is still flowing into health startups that mix hardware, data and consumer-facing medical services.

The company said the financing is a Series C, meaning a later-stage venture capital round typically used by startups that already have a product in market and are trying to expand. Lightspeed Venture Partners and O.G. Venture Partners led the round, according to Neko Health.

The raise comes after Neko Health announced a $260 million Series B in January 2025. Other participants in the new round include Atomico, General Catalyst, Lakestar, Liberty City Ventures, Positive Sum, and BDT & MSD, according to the company.

What Neko Health does

Neko Health offers health assessments built around its own body-scanning technology and blood tests. The idea is to gather a broad set of physical and clinical signals during a visit, then use that information to help clinicians review a person’s health.

The company says its scan now includes body composition information, a metric that can cover how the body is made up, such as fat and lean mass. Neko Health can also connect its assessments with Apple Health data. Nilsonne said in a LinkedIn post that the Apple Health connection gives the company’s medical clinicians more real-world data to use when assessing patients.

Neko Health currently operates in Sweden and the U.K. The company said it is preparing to open its first U.S. location in New York.

Demand before the U.S. debut

Neko Health said more than 100,000 people have completed scans so far. The company also said more than 350,000 people have either joined its waitlist or booked an appointment.

One patient case cited publicly came from Alex Tew, founder of Calm. Tew wrote on X that a Neko Health scan identified a malignant mole on his back, which he then had removed. “I’m grateful to Neko for helping me discover this – I’m not sure how I would have otherwise,” Tew wrote.

That kind of example is central to how preventive health companies explain their pitch: catching potential issues earlier by combining sensors, lab work and clinician review. The business model still depends on execution, medical trust and regulatory handling as companies expand into new markets.

A growing category

Neko Health is one of several technology-linked efforts moving into full-body health scanning. MidJourney, the AI lab known for image and video generation tools, has said it is developing a body scanner of its own. MidJourney has said it plans to place that scanner inside a spa-style setting with hot tubs and saunas in San Francisco, with an opening planned for sometime in 2027.

For Neko Health, the new funding gives the company more room to build clinics and support a U.S. launch. For public-market investors, there is no direct stock to trade in Neko Health, but the round adds to a broader trend: venture investors continue to back private companies trying to turn preventive care into a consumer product.

This story draws on original reporting from TechCrunch.